Company / Free Cash Flow
Insulet Corporation Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$377.7M
FY2025
5-year range
-$180.0M / $377.7M
FY2021-FY2025
Trend
+23.7%
vs FY2024
Sector context
#47 of 145
Health Care
What the data says
At $378M, Insulet Corporation's free cash flow ranks #47 of 145 in the Health Care sector. Free Cash Flow has increased for 4 consecutive years, from -$180M in FY2021 to $378M in FY2025.
Based on SEC 10-K filings.
$378M in FY2025.
Improved from $70M to $378M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#47 of 145 in Health CareTop 32% of 145This company $377.7M Sector average $770.9M
▼
-51.0% below sector average
Key checks
Key Insights
- Insulet Corporation's free cash flow has grown for 4 consecutive years.
- In FY2025, free cash flow increased 23.7% year-over-year.
- Ranks #47 out of 145 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $377.7M | +23.7% |
| FY2024 | $305.3M | +335.5% |
| FY2023 | $70.1M | +1897.4% |
| FY2022 | -$3.9M | +97.8% |
| FY2021 | -$180.0M | -300.0% |
| FY2020 | -$45.0M | +31.1% |
| FY2019 | -$65.3M | +46.3% |
| FY2018 | -$121.5M | -273.8% |
| FY2017 | -$32.5M | -423.9% |
| FY2016 | -$6.2M | +73.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026